| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 26 |
| 1 | GABAPENTIN | 23 |
| 2 | LAMIVUDINE ORAL | 17 |
| 3 | RITONAVIR | 17 |
| 4 | ABACAVIR SULFATE | 16 |
| 5 | FINASTERIDE | 16 |
| 6 | ONABOTULINUMTOXINA | 15 |
| 7 | ATAZANAVIR | 14 |
| 8 | ZIDOVUDINE | 14 |
| 9 | ASPIRIN | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | 1 | 0.0081 |
| 1 | NELFINAVIR MESYLATE | 5 | 0.0024 |
| 2 | HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE | 1 | 0.0023 |
| 3 | URINARY PAIN RELIEF | 1 | 0.0021 |
| 4 | CANDIDA ALBICANS, WOOD CREOSOTE, SODIUM CHLORIDE, AND SULFUR | 1 | 0.0021 |
| 5 | SULFACETAMIDE SODIUM | 1 | 0.0020 |
| 6 | ACONITUM NAPELLUS, ARSENIC TRIOXIDE, CITRULLUS COLOCYNTHIS FRUIT PULP, PSEUDOGNAPHALIUM OBTUSIFOLIUM, AND MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE | 1 | 0.0020 |
| 7 | CALCIUM SULFATE ANHYDROUS | 1 | 0.0019 |
| 8 | CALCIUM FLUORIDE | 1 | 0.0019 |
| 9 | DIBASIC POTASSIUM PHOSPHATE | 1 | 0.0018 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 4 | 0.0022 |
| 1 | Non-Standardized Fungal Allergenic Extract [EPC] | 2 | 0.0009 |
| 2 | Cytolytic Agent [EPC] | 2 | 0.0009 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 37 | 0.0008 |
| 4 | Protease Inhibitor [EPC] | 22 | 0.0005 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 50 | 0.0005 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 26 | 0.0004 |
| 7 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 10 | 0.0004 |
| 8 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 9 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |